News | January 06, 2023
PMBI launches Jan Aushadhi Chyawanprash Special
Chyawanprash Special will be available at all Jan Aushadhi Kendras
Chyawanprash Special will be available at all Jan Aushadhi Kendras
The current ruling will assure the safety of the use of Ranitidine for Indian patients
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Revenue is up 23% whereas Profit After Tax expands 29% for the company
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
Sandoz is planned to be incorporated in Switzerland and to be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US
Phase 1 has already been executed with the construction of temporary OPD, guest house and boundary wall and Phase 2 of the execution is being fast tracked
Subscribe To Our Newsletter & Stay Updated
